DrugRisk Alerts New Study Warns of Pradaxa Bleeding Risks as Lawsuits Increase
Chicago, IL (PRWEB) July 31, 2013 -- The prescription drug resource center DrugRisk.com is announcing updated information for patients taking the blood thinner Pradaxa. A new study from the Netherlands suggests the risk for internal bleeding is higher with drugs like Pradaxa, as a federal court reports rising lawsuits from patients*.
DrugRisk provides patients taking popular prescription drugs with the latest warnings, recalls, studies and legal news to improve safety and awareness. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.
Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation. Experts disagree, however, about its risks for internal bleeding. The FDA has advised Pradaxa is no more dangerous than traditional blood thinner warfarin**.
Others, like the Institute for Safe Medication Practices, have warned that patients may be nearly 5 times as likely to die from bleeding with Pradaxa than that from warfarin***.
Now, the resource center has learned of a study published this month from the Netherlands which suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding*.
Due to the growing number of patients who have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.
The latest report from the Judicial Panel on Multidistrict Litigation shows the number of cases filed has nearly doubled, from 663 on May 15th to 1,133 on July 10****. Judge David Herndon, who is overseeing the cases, recently blocked attempts by drug maker Boehringer Ingelheim to dismiss litigation*****.
Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugRisk.com or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.
Visit http://www.DrugRisk.com today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.
*Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****JPML 7/10/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-July-10-2013.pdf
*****Judge David Herndon, 7/18/13; aboutlawsuits.com/wp-content/uploads/2013-07-18-Jackson-Order.pdf
Patient Advocate, DrugRisk, http://www.DrugRisk.com, 888-415-1859, [email protected]
Share this article